Pfizer Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 24,290 million compared to USD 23,838 million a year ago. Net income was USD 4,995 million compared to USD 3,393 million a year ago.

Basic earnings per share from continuing operations was USD 0.89 compared to USD 0.64 a year ago. Diluted earnings per share from continuing operations was USD 0.87 compared to USD 0.62 a year ago. Basic earnings per share was USD 0.89 compared to USD 0.6 a year ago.

Diluted earnings per share was USD 0.87 compared to USD 0.59 a year ago.